2399.TW
Biostar Microtech International Corp. [2399.TW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2399.TW Stock Summary
In the News
2399.TW Financial details
Company Rating
Buy
Market Cap
4.31B
Income
33.56M
Revenue
2.28B
Book val./share
12.35
Cash/share
6.2
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
129.02
Forward P/E
-
PEG
-14.23
P/S
1.82
P/B
1.89
P/C
3.76
P/FCF
768.9
Quick Ratio
3.13
Current Ratio
5.11
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-96.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-5.96%
Revenue Q/Q
-21.64%
EPS Q/Q
-33.33%
-
-
-
-
SMA20
-
SMA50
-7.69%
SMA100
60%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
-
Gross Margin
8%
Oper. Margin
-
Profit Margin
1%
Payout
-
Shs Outstand
178.1M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
11.15-28.6
52W High
-16.79%
52W Low
+111.82%
RSI
48
Rel Volume
0.17
Avg Volume
6.87M
Volume
1.17M
Perf Week
-3.72%
Perf Month
2.87%
Perf Quarter
47%
Perf Half Y
39.52%
-
-
-
-
Beta
0.928856
-
-
Volatility
0.36%, 0.62%
Prev Close
-1.06%
Price
23.3
Change
-2.92%
2399.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 17.07 | 12.8 | 11.82 | 15.58 | 12.56 | |
| Net income per share | -1.37 | 0.26 | 0.8 | 2.03 | 0.07 | |
| Operating cash flow per share | -0.48 | 1.84 | -0.52 | 0.51 | -0.45 | |
| Free cash flow per share | -1.06 | 1.69 | -0.54 | 0.5 | -0.47 | |
| Cash per share | 4.73 | 6.47 | 8.43 | 8.75 | 6.76 | |
| Book value per share | 11.17 | 11.23 | 12.07 | 13.65 | 12.62 | |
| Tangible book value per share | 12.82 | 12.93 | 12.07 | 13.65 | 12.62 | |
| Share holders equity per share | 11.17 | 11.23 | 12.07 | 13.65 | 12.62 | |
| Interest debt per share | 0.57 | 0.59 | 0.03 | 0.02 | 0.04 | |
| Market cap | 1.72B | 2.16B | 3.07B | 4.38B | 2.37B | |
| Enterprise value | 1.23B | 1.5B | 2.47B | 3.73B | 1.63B | |
| P/E ratio | -7.07 | 46.98 | 21.53 | 12.11 | 184.32 | |
| Price to sales ratio | 0.57 | 0.95 | 1.46 | 1.58 | 1.06 | |
| POCF ratio | -20.33 | 6.58 | -33.04 | 47.87 | -29.33 | |
| PFCF ratio | -9.12 | 7.18 | -32.13 | 49.11 | -28.59 | |
| P/B Ratio | 0.86 | 1.08 | 1.43 | 1.8 | 1.05 | |
| PTB ratio | 0.86 | 1.08 | 1.43 | 1.8 | 1.05 | |
| EV to sales | 0.41 | 0.66 | 1.18 | 1.34 | 0.73 | |
| Enterprise value over EBITDA | -11.23 | 12.96 | 12.38 | 9.56 | 67.34 | |
| EV to operating cash flow | -14.58 | 4.59 | -26.6 | 40.78 | -20.15 | |
| EV to free cash flow | -6.55 | 5.01 | -25.87 | 41.83 | -19.64 | |
| Earnings yield | -0.14 | 0.02 | 0.05 | 0.08 | 0.01 | |
| Free cash flow yield | -0.11 | 0.14 | -0.03 | 0.02 | -0.03 | |
| Debt to equity | 0.05 | 0.05 | 0 | 0 | 0 | |
| Debt to assets | 0.03 | 0.03 | 0 | 0 | 0 | |
| Net debt to EBITDA | 4.43 | -5.62 | -2.99 | -1.66 | -30.68 | |
| Current ratio | 3 | 2.7 | 3.78 | 3.3 | 4.28 | |
| Interest coverage | -97.98 | 47.48 | 454.6 | 7.64K | 140.24 | |
| Income quality | 0.42 | 4.94 | -0.48 | 0.22 | -4.98 | |
| Dividend Yield | 0.08 | 0 | 0 | 0.02 | 0.09 | |
| Payout ratio | -0.59 | 0 | 0 | 0.2 | 16.63 | |
| Sales general and administrative to revenue | 0.04 | 0.06 | 0.04 | 0.03 | 0.02 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | |
| Intangibles to total assets | 0.06 | 0.05 | 0.39 | 0.34 | 0.1 | |
| Capex to operating cash flow | 1.23 | -0.08 | 0.03 | -0.03 | 0.03 | |
| Capex to revenue | -0.03 | -0.01 | 0 | 0 | 0 | |
| Capex to depreciation | -1.17 | -0.69 | -0.15 | -0.29 | -0.32 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 18.53 | 8.07 | 14.75 | 24.98 | 4.53 | |
| ROIC | -0.03 | 0.03 | 0.07 | 0.14 | 0.01 | |
| Return on tangible assets | -0.09 | 0.02 | 0.08 | 0.17 | 0.01 | |
| Graham Net | 4.16 | 4.86 | 7.34 | 7.42 | 6.69 | |
| Working capital | 1.35B | 1.3B | 1.73B | 1.91B | 1.72B | |
| Tangible asset value | 2.11B | 2.13B | 1.05B | 1.33B | 1.96B | |
| Net current asset value | 1.27B | 1.26B | 1.7B | 1.88B | 1.68B | |
| Invested capital | 0.05 | 0.05 | 0 | 0 | 0 | |
| Average receivables | 495.65M | 358.56M | 286.51M | 179.53M | 144.13M | |
| Average payables | 536.4M | 404.7M | 438.43M | 479.32M | 434.19M | |
| Average inventory | 848.98M | 632.89M | 559.47M | 820.97M | 961.49M | |
| Days sales outstanding | 41.82 | 59.05 | 35.41 | 20.37 | 21.77 | |
| Days payables outstanding | 48.55 | 79.98 | 85.45 | 85.04 | 63.64 | |
| Days of inventory on hand | 101.94 | 89.72 | 122.52 | 165.21 | 167.39 | |
| Receivables turnover | 8.73 | 6.18 | 10.31 | 17.92 | 16.77 | |
| Payables turnover | 7.52 | 4.56 | 4.27 | 4.29 | 5.74 | |
| Inventory turnover | 3.58 | 4.07 | 2.98 | 2.21 | 2.18 | |
| ROE | -0.12 | 0.02 | 0.07 | 0.15 | 0.01 | |
| Capex per share | -0.58 | -0.15 | -0.01 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 2.86 | 3.09 | 2.85 | 3.95 | 2.91 | |
| Net income per share | -0.08 | 0.18 | -0.24 | 0.15 | 0.1 | |
| Operating cash flow per share | -0.68 | 0.24 | 0.24 | -0.29 | -0.15 | |
| Free cash flow per share | -0.68 | 0.24 | 0.23 | -0.29 | -0.15 | |
| Cash per share | 7.67 | 6.63 | 6.76 | 6.6 | 6.2 | |
| Book value per share | 12.98 | 12.96 | 12.62 | 13 | 12.35 | |
| Tangible book value per share | 12.98 | 12.96 | 12.62 | 13 | 12.35 | |
| Share holders equity per share | 12.98 | 12.96 | 12.62 | 13 | 12.35 | |
| Interest debt per share | 0.02 | 0.01 | 0.04 | 0.03 | 0.03 | |
| Market cap | 2.55B | 2.16B | 2.37B | 2.79B | 4.31B | |
| Enterprise value | 1.9B | 1.55B | 1.63B | 2.11B | 3.7B | |
| P/E ratio | -46.25 | 17.01 | -13.77 | 26.58 | 58 | |
| Price to sales ratio | 5.18 | 3.96 | 4.67 | 4.04 | 7.97 | |
| POCF ratio | -21.87 | 50.38 | 56.2 | -55.42 | -157.52 | |
| PFCF ratio | -21.76 | 51.07 | 57.45 | -55.42 | -154.99 | |
| P/B Ratio | 1.14 | 0.95 | 1.05 | 1.23 | 1.88 | |
| PTB ratio | 1.14 | 0.95 | 1.05 | 1.23 | 1.88 | |
| EV to sales | 3.85 | 2.84 | 3.21 | 3.06 | 6.84 | |
| Enterprise value over EBITDA | -1.63K | 111.62 | -38.36 | 72.02 | 481.12 | |
| EV to operating cash flow | -16.26 | 36.17 | 38.61 | -41.99 | -135.13 | |
| EV to free cash flow | -16.18 | 36.66 | 39.46 | -41.99 | -132.95 | |
| Earnings yield | -0.01 | 0.01 | -0.02 | 0.01 | 0 | |
| Free cash flow yield | -0.05 | 0.02 | 0.02 | -0.02 | -0.01 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 563.54 | -43.85 | 17.48 | -23.03 | -79.73 | |
| Current ratio | 3.21 | 4.7 | 4.28 | 4.27 | 5.11 | |
| Interest coverage | -492.4 | 2.56K | -410.53 | 1.03K | 73.67 | |
| Income quality | 44.95 | 3.42 | -0.92 | -1.81 | -4.93 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
| Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0 | 0 | 0.1 | 0.09 | 0.26 | |
| Capex to operating cash flow | 0 | -0.01 | -0.02 | 0 | 0.02 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.44 | -0.53 | -0.33 | 0 | -0.28 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.83 | 7.24 | 8.28 | 6.62 | 5.27 | |
| ROIC | -0.01 | 0.01 | -0.02 | 0.01 | 0.01 | |
| Return on tangible assets | 0 | 0.01 | -0.02 | 0.01 | 0.01 | |
| Graham Net | 6.6 | 6.99 | 6.69 | 6.77 | 6.68 | |
| Working capital | 1.73B | 1.77B | 1.72B | 1.72B | 1.75B | |
| Tangible asset value | 2.24B | 2.29B | 1.96B | 2.01B | 1.56B | |
| Net current asset value | 1.69B | 1.73B | 1.68B | 1.69B | 1.71B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 189.96M | 186.58M | 161.51M | 170.34M | 192.19M | |
| Average payables | 358.08M | 255.53M | 293.86M | 350.91M | 318.22M | |
| Average inventory | 1.01B | 931.44M | 882.99M | 883.13M | 849.27M | |
| Days sales outstanding | 33.53 | 31.28 | 23.66 | 27.03 | 29.47 | |
| Days payables outstanding | 57.78 | 43.66 | 64.46 | 51.79 | 50.27 | |
| Days of inventory on hand | 216.7 | 154.13 | 169.55 | 124.73 | 151.09 | |
| Receivables turnover | 2.68 | 2.88 | 3.8 | 3.33 | 3.05 | |
| Payables turnover | 1.56 | 2.06 | 1.4 | 1.74 | 1.79 | |
| Inventory turnover | 0.42 | 0.58 | 0.53 | 0.72 | 0.6 | |
| ROE | -0.01 | 0.01 | -0.02 | 0.01 | 0.01 | |
| Capex per share | 0 | 0 | -0.01 | 0 | 0 |
2399.TW Frequently Asked Questions
What is Biostar Microtech International Corp. stock symbol ?
Biostar Microtech International Corp. is a TW stock and trading under the symbol 2399.TW
What is Biostar Microtech International Corp. stock quote today ?
Biostar Microtech International Corp. stock price is $23.3 today.
Is Biostar Microtech International Corp. stock public?
Yes, Biostar Microtech International Corp. is a publicly traded company.
Company Profile
- Volume Average 6.87M
- Market Capitalization 4.31B
- Headquarters New Taipei City,TW
- IPO Date 2000-01-04
-
Website
https://www.biostar.com.tw 
Biostar Microtech International Corp. engages in the design, manufacture, and sale of add-on cards, and multi-media and system products in Taiwan and internationally. The company offers motherboards, SSD and SOC products, keyboards/mouses, VGA and IPC products, crypto mining motherboards, and accessories. It also provides accessories, such as cables, headsets, brackets, dongles, IO shields, and other products. The company was founded in 1986 and is based in New Taipei City, Taiwan.
